Importance of checking anti-glomerular basement membrane antibody status in patients with antineutrophil cytoplasmic antibody-positive vasculitis

Postgraduate Medical Journal

Volumn 84, Issue 990, 2008, Pages 220-222

  Gallagher, J L ^a   Sinha, S ^a   Reeve, R ^a   Kalra, P A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; HEMOGLOBIN; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DIALYSIS; GLOMERULONEPHRITIS; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LIVER FUNCTION TEST; MALE; MEGALOCYTOSIS; OLIGURIA; SIDE EFFECT;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; VASCULITIS;

EID: 42649100297     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.062752     Document Type: Article

References (11)

1. Levy JB, Hammad T, Coulthart A, et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004;66:1535-40.
2. Yang G, Tang Z, Chen Y, et al. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol 2005;63:423-8.
3. Serratrice J, Chiche L, Dussol B, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004;43:e26-30.
4. Kitagawa W, Miura N, Yamada H, et al. The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis. Clin Exp Nephrol 2005;9:69-73.
5. Rutgers A, Slot M, van PP, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005;46:253-62.
6. Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 2004;17(Suppl 8):S10-19.
7. Verburgh CA, Bruijn JA, Daha MR, et al. Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis. Am J Kidney Dis 1999;34:344-8.
8. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
9. Levy JB, Turner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-42.
10. Heeringa P, Brouwer E, Klok PA, et al. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 1996;149:1695-706.
11. Rutgers A, Heeringa P, Damoiseaux JG, et al. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 2003;14:287-95.